Frankfurt Rhine-Main Metropolitan Area
Private Investments Health Care Consultancy or Board Membership
Developed the axicorp group over 10 years from a start up to a leading pharmaceutical company in Germany (No.30) with an annual turnover of 300M€. Main Business: EU-Pharmaceuticals, OTC, Generics, Clinical Trial Services and biosimilar development. Different succesful M&A transactions in Germany, UK, India Entrepreneur with an proven track record Awards: - E&Y Entrepreneur of the year 2008 Germany (Final) - Best Mid size company 2008, German founder prize - AxiCorp one of 22 growth champions 2010 (total mid size companies)
Key facts: Leading 400 M$ business, 470 people Member of the global leadership team which build up the woldwide activities in diabetes to reach 2 billion by end of 2006. customer awards: best diabetes company 2006, 2007; best product launch Germany 2002 and 2004